These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2307503)

  • 21. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
    Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved cardiac function in patients with obstructive jaundice after internal biliary drainage: hemodynamic and hormonal assessment.
    Padillo J; Puente J; Gómez M; Dios F; Naranjo A; Vallejo JA; Miño G; Pera C; Sitges-Serra A
    Ann Surg; 2001 Nov; 234(5):652-6. PubMed ID: 11685028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.
    Wójcicki J; Sulikowski T; Wójcicki M; Droździk M; Gawrońska-Szklarz B; Barcew-Wiszniewska B; Skowron J; Rózewicka L
    Br J Pharmacol; 1996 Jan; 117(1):1-4. PubMed ID: 8825335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery patterns of liver function after complete and partial surgical biliary decompression.
    Watanapa P
    Am J Surg; 1996 Feb; 171(2):230-4. PubMed ID: 8619456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of percutaneous transhepatic biliary drainage in the correction of the metabolic capacity of the jaundiced liver by hippurate-synthesizing test.
    Kamiyama Y; Tokunaga Y; Aoyama H; Ukikusa M; Ozawa K
    Surg Gynecol Obstet; 1993 Jul; 177(1):72-6. PubMed ID: 8322155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A; Lowicki Z; Chmara E; Mrozikiewicz A; Baczyk K
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):339-41. PubMed ID: 2235722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites.
    St Peter JV; Awni WM
    Clin Pharmacokinet; 1991 Jan; 20(1):50-65. PubMed ID: 2029802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipyrine clearance and metabolite formation in primary biliary cirrhosis.
    Jorquera F; Almar M; Linares A; Olcóz JL; Rodrigo L; González-Gallego J
    Dig Dis Sci; 2001 Feb; 46(2):352-9. PubMed ID: 11281185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice.
    Koyama K; Takagi Y; Ito K; Sato T
    Am J Surg; 1981 Aug; 142(2):293-9. PubMed ID: 6789695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
    Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
    Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a microcomputer in the assessment of diagnosis and risk in obstructive jaundice.
    Little JM
    Aust N Z J Surg; 1985 Dec; 55(6):575-8. PubMed ID: 3868996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
    Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
    Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.
    Loft S; Simonsen K; Evald T; Christensen HR; Sonne J; Døssing M
    Eur J Clin Pharmacol; 1987; 33(1):89-91. PubMed ID: 3691602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Tsukamoto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(27):1599-602. PubMed ID: 10430302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
    Chijiiwa K; Watanabe M; Nakano K; Noshiro H; Tanaka M
    Am J Surg; 2000 Feb; 179(2):161-6. PubMed ID: 10773154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The usefulness of biliary drainage for restoring liver function in obstructive jaundice.
    Fiori E; Atella F; Gazzanelli S; De Masi E; Lamazza A; Cangemi V; Piat G
    Panminerva Med; 1994 Dec; 36(4):171-8. PubMed ID: 7603733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.